Connection

Carol Sherman to Neoplasms, Unknown Primary

Back to Details
This is a "connection" page, showing publications Carol Sherman has written about Neoplasms, Unknown Primary.
Carol Sherman
Connection Strength
0.013
Neoplasms, Unknown Primary
  1. Irinotecan and gemcitabine in patients with solid tumors: phase I trial. Oncology (Williston Park). 2002 May; 16(5 Suppl 5):19-24.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.